{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:54:25Z","timestamp":1760061265301,"version":"build-2065373602"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, the main interest of analytical chemistry researchers has been the development of green analytical methods to minimize harmful effects on the environment and natural life. Therefore, an RP\u2010HPLC method was developed and assessed regarding its greenness criteria using three greenness assessment tools: an analytical eco\u2010scale, an analytical greenness metric approach and a green analytical procedure index. This method aims to separate and quantitatively determine three co\u2010administered drugs, namely pyridostigmine bromide (PYR), 6\u2010mercaptopurine (MRC) and prednisolone (PRD), in their tertiary mixture and spiked human plasma. These drugs are co\u2010administered to manage myasthenia gravis autoimmune disease. The separation was done using a C<jats:sub>18<\/jats:sub> column and a gradient elution of a mixture of 0.1% H<jats:sub>3<\/jats:sub>PO<jats:sub>4<\/jats:sub> aqueous solution (pH\u00a02.3) and methanol. The flow rate was adjusted to 1\u00a0ml\/min and detection was done at 254 (for PYR and PRD) and at 330\u2009nm (for MRC). The lower limits of quantitation were 15, 2, and 5\u00a0\u03bcg\/ml for PYR, MER and PRD, respectively. Linear correlations were obtained and found to be near 1. In addition, the proposed method was validated according to the US Food and Drug Administration's instructions, and the results proved its success to determine the three studied drugs in their tertiary mixture and spiked human plasma.<\/jats:p>","DOI":"10.1002\/bmc.5615","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T23:34:27Z","timestamp":1678232067000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A validated ecofriendly chromatographic method for determination of myasthenia gravis combined medications in spiked human plasma"],"prefix":"10.1002","volume":"37","author":[{"given":"Maimana A.","family":"Magdy","sequence":"first","affiliation":[{"name":"Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy Beni Suef University  Beni Suef Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal F.","family":"Farid","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy Beni Suef University  Beni Suef Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-9765","authenticated-orcid":false,"given":"Basma H.","family":"Anwar","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy Beni Suef University  Beni Suef Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nessreen S.","family":"Abdelhamid","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy Beni Suef University  Beni Suef Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoac\/94.5.1427"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.5155\/eurjchem.6.3.350-356.1283"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsac139"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4804"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/bio.4011"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00407-2"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/39.7.287"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1556\/1006.2015.28.4.8"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)99279-3"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(75)90125-8"},{"issue":"1","key":"e_1_2_7_12_1","first-page":"117","article-title":"Development and validation of spectrophotometric and HPLC method for the simultaneous estimation of salbutamol sulphate and prednisolone in tablet dosage form","volume":"2","author":"Chitlange S. S.","year":"2011","journal-title":"Analytical & Bioanalytical Techniques"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29894"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/419194"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201401151"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2018-0191"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmab093"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.1983.11702661"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)80245-5"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2012.03.013"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0AY02169E"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.10.045"},{"key":"e_1_2_7_23_1","unstructured":"Mayo Clinic. (2022).Myasthenia gravis. Retrieved April 25 2022 fromhttps:\/\/www.mayoclinic.org\/diseases-conditions\/myasthenia-gravis\/diagnosis-treatment\/drc-20352040"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412915666190715094347"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmz043"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2004000500004"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.0c01887"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2018.01.013"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826076.2012.749495"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2AY01462A"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.2116\/analsci.23.1241"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2014.11.026"},{"volume-title":"Medicines and healthcare products regulatory agency","year":"2013","author":"The British Pharmacopoeia","key":"e_1_2_7_33_1"},{"key":"e_1_2_7_34_1","unstructured":"The United States Pharmacopeia The Official Compendia of Standards USP 34\u2010NF 29. 2011.The United States Pharmacopeial Convention."},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2012.02.006"},{"volume-title":"Bioanalytical method validation guidance for industry","year":"2018","author":"US FDA","key":"e_1_2_7_36_1"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.63"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6RA07675K"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.5615","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bmc.5615","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.5615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:56:21Z","timestamp":1760046981000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.5615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1002\/bmc.5615"],"URL":"https:\/\/doi.org\/10.1002\/bmc.5615","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"type":"print","value":"0269-3879"},{"type":"electronic","value":"1099-0801"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"2022-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e5615"}}